Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Zvezda reported for 3 months of 2024 by RAS

5/3/24 ZVEZ

VK acquired 40% of Intickets.ru ticketing platform

5/3/24 VKCO

Samaraenergo reported for 3 months of 2024 by RAS

5/3/24 SAGO

Samaraenergo reported for 2023 by IFRS

5/3/24 SAGO

Sovcombank's shareholders approved an additional share issue for the purchase of Home Bank

5/3/24 SVCB

EL5-Energo reported for 3 months of 2024 by RAS

5/3/24 ELFV

INARCTICA reported for 3 months of 2024 by RAS

5/3/24 AQUA

Sovcombank reported for 3 months of 2024 by RAS

5/3/24 SVCB

Arsagera reported for 3 months of 2023 by RAS

5/3/24 ARSA

Artgen reported for 3 months of 2024 by RAS

5/3/24 ABIO